Where Does Ovarian Cancer Spread? What Happens When Cancer Cells Travel

Where does ovarian cancer spread? First to the adjacent pelvic organs: the uterus, fallopian tubes, bladder, and rectum. From there it sheds cells into the peritoneal fluid, which carries them upward to seed the peritoneum and omentum, then to the lymph nodes and eventually to distant sites like the liver and lungs.

That’s the short answer. The longer answer matters more, because knowing the pattern helps you ask sharper questions, read your scan reports with more confidence, and understand why your treatment plan looks the way it does.

Ovarian cancer is unusual among cancers in how it travels. Most cancers spread mainly through blood and lymph. Ovarian cancer does that too, but its dominant route is different: it sheds cells into fluid that already circulates through your abdomen, and that fluid does the traveling for it. Which is part of why it reaches so many places before anyone notices.

How Ovarian Cancer Spreads Through the Body

Cancer cells break away from the primary tumor in the ovary, fallopian tube, or peritoneum and travel by several routes at once.

• Peritoneal (transcoelomic) spread. Cells shed directly into the fluid of the peritoneal cavity and drift to new surfaces, where they implant and grow. This is the dominant route.
• Lymphatic spread. Cells enter lymphatic vessels and collect in lymph nodes, most often the para-aortic and pelvic nodes.
• Hematogenous spread. Cells enter the bloodstream and travel to distant organs.
• Nerve-related spread. A rarer route in which cancer cells migrate along or around nerves.

According to recent research, roughly two-thirds of patients with advanced high-grade serous ovarian cancer have metastases beyond the peritoneal cavity. Cells can’t get there by drifting across abdominal surfaces. They travel through blood vessels and lymphatic channels, which means those routes account for a substantial share of how the disease spreads.

Most metastasis research describes high-grade serous disease. Low-grade serous ovarian cancer accounts for roughly 6% to 8% of cases, and that rarity has left its spread patterns comparatively understudied. 

What we do know: LGSOC travels the same peritoneal route, just more slowly. Lymph node involvement is uncommon in early-stage disease but frequent once it advances, and it tends to cluster in the pelvis rather than the para-aortic region: the chain of nodes running alongside the aorta at the back of the abdomen, roughly level with your kidneys and belly button. That’s a departure from the typical high-grade pattern.

Where Does Ovarian Cancer Spread First?

The adjacent pelvic organs. Cancer extends directly into what it’s touching, then sheds cells into the peritoneal fluid, which seeds the peritoneum and omentum.

The earliest sites are usually:

• The surface of the other ovary and the fallopian tubes
• The uterus
• Nearby pelvic organs including the bladder, bowel, and rectum
• The peritoneum, the membrane lining the abdominal wall and organs
• The omentum, the apron of fatty tissue draped over your abdominal organs

That last step happens early, but it changes the staging. Disease confined to the pelvic organs is stage 2. Once it seeds the peritoneum or omentum, it’s stage 3.

The omentum deserves special attention. It’s a preferred landing site, and researchers think the fat cells there actively feed arriving cancer cells and release signaling molecules that help them take hold. When these deposits form on abdominal surfaces, they’re called peritoneal implants. You may see them described differently on your radiology reports: peritoneal carcinomatosis, nodularity, or omental caking all point to the same thing.

One more detail that surprises people: peritoneal fluid doesn’t stay put. Every breath you take pulls it upward, because the diaphragm creates a low-pressure zone above. And it travels along the right side of the abdomen more freely than the left, where a ligament blocks the path. That’s why implants show up more often on the upper right, along with the pouch of Douglas (the low point behind the uterus where fluid pools) and the greater omentum.

Where Does Ovarian Cancer Spread to Beyond the Pelvis?

Once cancer moves past the pelvis, the list expands. Here’s where it goes, roughly in order of how often it shows up.

Lymph nodes

The ovaries drain into the para-aortic and paracaval nodes, the pelvic iliac nodes, and occasionally the inguinal nodes. From there, cells can reach nodes in the chest. Research found lymph node involvement in 30% to 60% of patients with advanced high-grade serous disease.

There’s a hopeful wrinkle here. Some research suggests patients whose spread is confined to pelvic and para-aortic lymph nodes have better outcomes than those with widespread peritoneal disease at the same stage.

Liver

The liver is the single most common distant metastatic site. A study of 1,481 patients with metastatic ovarian cancer found the liver led the list, followed by distant lymph nodes, lung, bone, and brain. Liver involvement can cause abdominal pain, swelling, or jaundice.

Lungs and pleura

Cancer can reach the lungs themselves or, more commonly, the pleural space around them, causing fluid buildup and shortness of breath. Among patients diagnosed at stage 4, SEER data puts lung involvement at 38%.

Intestines

Bowel involvement is common and clinically significant, because tumor growth can obstruct the bowel. When surgeons need to remove a section, they usually reconnect the two ends. Sometimes a stoma is needed instead, often temporarily. If that’s on the table for you, our guide on “what is a colostomy” covers what to expect.

Rarer sites

Bones, brain and spinal cord, skin, and, in very rare cases, the breast. Bone involvement runs around 4%. Central nervous system spread is rarer still: SEER data found it in 1% of stage 4 patients, and an autopsy series — which catches disease no scan would have picked up — put it at 6%.

Spread and Metastasis are Not the Same Thing

This is where a lot of confusing advice lives online, so let’s be direct.

Cancer that has moved outside the ovary but stayed within the abdomen and pelvis is regional spread. It’s advanced, and it’s serious, and it’s treated aggressively. 

Surgery alone won’t cure stage 3 or 4 disease: the goal is to remove all visible disease and pair that with systemic treatment to reach long-term remission. Even then, up to three-quarters of patients relapse within two years. 

True distant metastasis is stage 4, and the line is more specific than most people expect. Disease sitting on the surface of the liver or spleen is still stage 3C. It’s stage 4 once it invades the liver tissue itself. And malignant fluid in the pleural space around the lungs counts as stage 4A on its own, with no visible lung mass required.

Most ovarian cancers — roughly three in four — are diagnosed at an advanced stage, most commonly stage 3 or 4. Most of that spread, though, is within the peritoneal cavity rather than in distant organs. 

That distinction matters. An advanced-stage diagnosis is serious, and it also covers a wide range of situations with meaningfully different treatment paths. Long-term remission is a realistic goal for many people, and when cancer does come back, recurrence is treated, not accepted. Our full guide to ovarian cancer staging breaks down what each number actually describes.

How Fast Does Ovarian Cancer Spread?

The honest answer is that it varies, and the timeline depends heavily on tumor grade.

Most high-grade serous cancers are now thought to begin in the fallopian tubes, and research suggests the earliest precancerous lesion there takes an average of about 6.5 years to become invasive cancer. Nothing is traveling during that window. The cells are accumulating mutations in place. Once the disease does turn invasive, though, it moves quickly.

Grade matters enormously. High-grade tumors grow and spread faster but usually respond better to platinum chemotherapy. Low-grade tumors grow slowly and often resist standard chemotherapy, which is why hormone therapy and targeted drugs play a bigger role in LGSOC care.

Symptoms that Suggest Ovarian Cancer has Spread

Early signs are famously vague. Bloating, pelvic pressure, feeling full quickly, urinary urgency. All of them get blamed on something else first.

Once cancer spreads, symptoms tend to sharpen:

• Nausea, vomiting, or constipation
• Abdominal swelling from ascites and ovarian cancer fluid buildup
• Back pain
• Unexplained weight loss alongside a swollen abdomen
• Shortness of breath or a persistent cough
• Jaundice or right-sided abdominal pain

None of these confirm spread on their own. If you’ve been diagnosed and something new shows up, tell your oncology team rather than waiting for your next scheduled visit.

How Doctors Find Out Where the Cancer has Spread

Surgery. For ovarian cancer, surgery is both treatment and staging. The surgeon inspects the abdomen directly, removes visible disease, and takes tissue samples from multiple sites. This remains the most accurate method.

Imaging. Cross-sectional imaging with CT or MRI is the standard for mapping disease before surgery. An ovarian cancer ultrasound can flag a suspicious mass, but it can’t map spread. If you’re wondering whether a CT scan can detect ovarian cancer, the answer is nuanced and worth reading in full. 

Staging typically includes a CT of the chest along with the abdomen and pelvis — not a chest X-ray, which isn’t sensitive enough to be part of the recommendation. PET scans and CT-guided biopsies fill in the remaining gaps.

How Spread Changes Treatment

Treatment for widespread disease usually pairs surgery with systemic drugs.

Debulking surgery for ovarian cancer aims to remove as much visible tumor as possible, sometimes including portions of the bowel, spleen, or liver surface. The amount of disease left behind is one of the strongest predictors of outcome, which is one reason your choice of surgeon matters so much. Ask for a gynecologic oncologist and ask how many of these operations they perform each year.

For some patients with widespread peritoneal disease, surgeons add hyperthermic intraperitoneal chemotherapy or HIPEC: heated chemotherapy delivered directly into the abdominal cavity at the end of debulking surgery, while the abdomen is still open. 

The logic follows the spread pattern: if the disease seeded surfaces throughout the peritoneum, treating those surfaces directly makes sense. It isn’t standard for everyone, and eligibility depends on how much disease was removed and how well you’re expected to tolerate it. Worth asking your surgeon whether it applies to your case.

Chemotherapy for ovarian cancer reaches cells anywhere in the body. Standard first-line treatment is typically a platinum and taxane combination, sometimes with bevacizumab. Maintenance therapy depends on your tumor’s genetic profile.

For LGSOC specifically, hormone-blocking drugs and MEK inhibitors have become central, because response rates to conventional chemotherapy are low. 

Ask Questions that Matter

Knowing how ovarian cancer moves through the body won’t change a diagnosis. But it makes the conversations ahead easier to follow, and it puts you in a better position to ask the questions that matter.

A few that are worth raising with your team: Where exactly has my disease spread, and how was that determined? Does the extent of spread change what surgery can accomplish? Has my tumor been tested for genetic changes that might open up targeted options? And what new symptoms should prompt me to call rather than wait for my next appointment?

Spread is also not a one-time finding. It gets reassessed through imaging, bloodwork, and follow-up visits, which means the picture can change in both directions over the course of treatment.

If something new shows up in your body, tell your oncology team. You know your own baseline better than any scan does.